%	O
%	O
TITLE	O

The	O
role	O
of	O
human	O
papillomavirus	O
in	O
head	O
and	O
neck	O
cancer	O
in	O
Senegal	B-Study_Location
.	O

%	O
%	O
ABSTRACT	O

Exploring	O
the	O
presence	O
and	O
role	O
of	O
human	O
papillomavirus	O
(	O
HPV	O
)	O
in	O
head	O
and	O
neck	O
cancer	O
(	O
HNC	O
)	O
is	O
a	O
necessary	O
step	O
to	O
evaluate	O
the	O
potential	O
impact	O
of	O
HPV	O
prophylactic	O
vaccines	O
.	O
To	O
assess	O
the	O
prevalence	B-Incidence_or_Prevalence
and	O
oncogenic	O
role	O
of	O
HPV	O
in	O
HNC	O
in	O
Senegal	B-Study_Location
.	O
This	O
is	O
a	O
multicenter	B-Study_Type
cross	I-Study_Type
-	I-Study_Type
sectional	I-Study_Type
study	I-Study_Type
.	I-Study_Type

Paraffin	O
-	O
embedded	O
blocks	O
of	O
cases	O
diagnosed	O
with	O
invasive	O
HNC	O
between	O
2002	B-Study_Time
and	I-Study_Time
2010	I-Study_Time
were	O
collected	O
from	O
4	O
pathology	O
laboratories	O
in	O
Senegal	B-Study_Location
.	O

Presence	O
of	O
HPV	O
DNA	O
was	O
determined	O
by	O
PCR	B-HPV_Lab_Technique
and	O
DEIA	O
,	O
and	O
genotyping	O
performed	O
with	O
LiPA25	O
.	O

Tubulin	O
analysis	O
was	O
performed	O
to	O
assess	O
DNA	O
quality	O
.	O

HPV	O
DNA	O
-	O
positive	O
cases	O
were	O
tested	O
for	O
p16INK4a	O
expression	O
.	O
A	B-Study_Cohort
total	I-Study_Cohort
of	I-Study_Cohort
117	I-Study_Cohort
cases	I-Study_Cohort
were	I-Study_Cohort
included	I-Study_Cohort
in	I-Study_Cohort
the	I-Study_Cohort
analysis	I-Study_Cohort
:	O
71	O
%	O
were	O
men	O
,	O
mean	O
age	O
was	O
52â€‰years	O
old	O
(	O
SD	O
Â±18	O
.	O
3	O
)	O
,	O
and	O
96	O
%	O
of	O
cases	O
were	O
squamous	O
cell	O
carcinoma	O
.	O

Analysis	O
was	O
performed	O
on	O
41	O
oral	O
cavity	O
tumors	O
,	O
64	O
laryngeal	O
tumors	O
,	O
5	O
oropharyngeal	O
tumors	O
and	O
7	O
pharyngeal	O
tumors	O
.	O

Only	O
four	O
cases	O
(	O
3	O
.	O
4	O
%	O
;	O
95	O
%	O
CIâ€‰=â€‰0	O
.	O
9	O
%	O
-	O
8	O
.	O
5	O
%	O
)	O
harbored	O
HPV	O
DNA	O
.	O

HPV	O
types	O
detected	O
were	O
HPV16	O
,	O
HPV35	O
and	O
HPV45	O
.	O

However	O
,	O
among	O
HPV	O
-	O
positive	O
cases	O
,	O
none	O
showed	O
p16INK4a	O
overexpression	O
.	O
Our	O
findings	O
indicate	O
that	O
HPV	O
DNA	O
prevalence	B-Incidence_or_Prevalence
in	O
HNC	O
in	O
Senegal	B-Study_Location
is	O
very	O
low	O
,	O
suggesting	O
that	O
HPV	O
is	O
not	O
a	O
strong	O
risk	O
factor	O
for	O
these	O
cancers	O
.	O

Additional	O
larger	O
studies	O
are	O
needed	O
to	O
confirm	O
these	O
findings	O
and	O
explore	O
other	O
potential	O
risk	O
factors	O
specific	O
to	O
the	O
region	O
.	O

%	O
%	O
MATERIAL	O
AND	O
METHODS	O

This	O
is	O
a	O
cross	B-Study_Type
-	I-Study_Type
sectional	I-Study_Type
study	I-Study_Type
designed	O
and	O
coordinated	O
by	O
the	O
Catalan	O
Institute	O
of	O
Oncology	O
in	O
Barcelona	O
and	O
is	O
part	O
of	O
a	O
large	O
international	O
study	O
on	O
HPV	O
in	O
HNC	O
.	O

Four	O
major	O
centers	O
in	O
Dakar	B-Study_Location
,	I-Study_Location
Senegal	I-Study_Location
,	O
have	O
provided	O
consecu	O
-	O
tive	O
cases	O
diagnosed	O
with	O
HNC	O
from	O
2002	B-Study_Time
to	I-Study_Time
2010	I-Study_Time
:	O
Centre	O
Hospitalier	O
Universitaire	O
A	O
.	O

Le	O
Dantec	O
,	O
Hôpital	O
Principal	O
de	O
Dakar	O
,	O
Hôpital	O
Général	O
de	O
Grand	O
Yoff	O
and	O
the	O
path	O
-	O
ology	O
laboratory	O
at	O
Cheikh	O
Anta	O
Diop	O
University	O
.	O

For	O
each	O
specimen	B-HPV_Sample_Type
,	O
after	O
pathological	O
confirmation	O
of	O
invasive	O
diag	O
-	O
nosis	O
,	O
a	O
paraffin	O
tissue	B-HPV_Sample_Type
section	O
was	O
treated	O
with	O
250	O
μl	O
of	O
freshly	O
prepared	O
Proteinase	O
K	O
solution	O
to	O
extract	O
DNA	O
.	O

©	O
2013	O
Ndiaye	O
et	O
al	O
.	O
;	O
licensee	O
BioMed	O
Central	O
Ltd	O
.	O

This	O
is	O
an	O
Open	O
Access	O
article	O
distributed	O
under	O
the	O
terms	O
of	O
the	O
Creative	O
Commons	O
Attribution	O
License	O
which	O
permits	O
unrestricted	O
use	O
,	O
distribution	O
,	O
and	O
reproduction	O
in	O
any	O
medium	O
,	O
provided	O
the	O
original	O
work	O
is	O
properly	O
cited	O
.	O

SPF	O
-	O
10	O
polymerase	B-HPV_Lab_Technique
chain	I-HPV_Lab_Technique
reaction	I-HPV_Lab_Technique
(	I-HPV_Lab_Technique
PCR	I-HPV_Lab_Technique
)	I-HPV_Lab_Technique
was	O
performed	O
using	O
10	O
μl	O
of	O
a	O
1	O
:	O
10	O
dilution	O
of	O
the	O
crude	O
DNA	O
extract	O
in	O
a	O
final	O
reaction	O
volume	O
of	O
50	O
μl	O
.	O

The	O
amplified	O
PCR	B-HPV_Lab_Technique
prod	O
-	O
ucts	O
were	O
tested	O
using	O
a	O
probe	O
hybridization	O
step	O
with	O
a	O
cocktail	O
of	O
conservative	O
probes	O
that	O
can	O
recognize	O
around	O
54	O
mucosal	O
HPV	O
genotypes	O
using	O
a	O
microtiter	O
plate	O
format	O
for	O
the	O
detection	O
of	O
HPV	O
DNA	O
through	O
a	O
DNA	O
enzyme	O
immunoassay	O
(	O
DEIA	O
)	O
(	O
produced	O
by	O
DDL	O
,	O
Voorburg	O
,	O
the	O
Netherlands	O
)	O
.	O

Optical	O
densities	O
(	O
OD450	O
)	O
were	O
read	O
on	O
a	O
microtiter	O
plate	O
reader	O
and	O
categorized	O
as	O
HPV	O
DNA	O
negative	O
,	O
positive	O
,	O
or	O
borderline	O
.	O

After	O
PCR	B-HPV_Lab_Technique
,	O
10	O
μl	O
of	O
the	O
DEIA	O
HPV	O
DNA	O
positive	O
amplimers	O
were	O
used	O
to	O
per	O
-	O
form	O
the	O
reverse	B-HPV_Lab_Technique
hybridization	I-HPV_Lab_Technique
line	I-HPV_Lab_Technique
probe	I-HPV_Lab_Technique
assay	I-HPV_Lab_Technique
(	I-HPV_Lab_Technique
LiPA25	I-HPV_Lab_Technique
)	I-HPV_Lab_Technique
(	I-HPV_Lab_Technique
version	I-HPV_Lab_Technique
1	I-HPV_Lab_Technique
:	I-HPV_Lab_Technique
produced	I-HPV_Lab_Technique
by	I-HPV_Lab_Technique
DDL	I-HPV_Lab_Technique
,	I-HPV_Lab_Technique
Voorburg	I-HPV_Lab_Technique
,	I-HPV_Lab_Technique
the	I-HPV_Lab_Technique
Netherlands	I-HPV_Lab_Technique
)	I-HPV_Lab_Technique
.	O

The	O
LiPA25	O
detects	O
25	O
high	O
-	O
risk	O
and	O
low	O
-	O
risk	O
HPV	O
types	O
(	O
6	O
,	O
11	O
,	O
16	O
,	O
18	O
,	O
31	O
,	O
33	O
,	O
34	O
,	O
35	O
,	O
39	O
,	O
40	O
,	O
42	O
,	O
43	O
,	O
44	O
,	O
45	O
,	O
51	O
,	O
52	O
,	O

53	O
,	O
54	O
,	O
56	O
,	O
58	O
,	O
59	O
,	O
66	O
,	O
68	O
,	O
70	O
,	O
and	O
74	O
)	O
.	O

Additionally	O
,	O
amplifi	O
-	O
cation	O
of	O
the	O
human	O
tubulin	O
gene	O
was	O
performed	O
to	O
deter	O
-	O
mine	O
DNA	O
quality	O
of	O
DEIA	O
negative	O
samples	B-HPV_Sample_Type
.	I-HPV_Sample_Type

In	O
HPV	O
DNA	O
-	O
positive	O
samples	B-HPV_Sample_Type
,	O
p16INK4a	B-HPV_Lab_Technique
overexpression	I-HPV_Lab_Technique
was	I-HPV_Lab_Technique
eval	I-HPV_Lab_Technique
-	I-HPV_Lab_Technique
uated	I-HPV_Lab_Technique
using	I-HPV_Lab_Technique
CINtec	I-HPV_Lab_Technique
histology	I-HPV_Lab_Technique
kit	I-HPV_Lab_Technique
(	I-HPV_Lab_Technique
clone	I-HPV_Lab_Technique
E6H4	I-HPV_Lab_Technique
,	I-HPV_Lab_Technique
mtm	I-HPV_Lab_Technique
La	I-HPV_Lab_Technique
-	I-HPV_Lab_Technique
boratories	I-HPV_Lab_Technique
,	I-HPV_Lab_Technique
Heidelberg	I-HPV_Lab_Technique
,	I-HPV_Lab_Technique
Germany	I-HPV_Lab_Technique
)	O
in	O
order	O
to	O
verify	O
the	O
potential	O
causal	O
role	O
of	O
HPV	O
in	O
positive	O
cases	O
.	O

Overall	O
HPV	O
detection	O
percentages	O
and	O
95	O
%	O
confidence	O
intervals	O
(	O
95	O
%	O
CI	O
)	O
were	O
estimated	O
.	O

Data	O
analyses	O
were	O
performed	O
with	O
STATA	O
11	O
.	O
0	O
.	O

Ethical	O
approval	O
was	O
obtained	O
from	O
the	O
Ministry	O
of	O
Health	O
of	O
Senegal	B-Study_Location
.	O

